Inhibitory effect of atorvastatin on the cell growth of cardiac myxomas via the PTEN and PHLPP2 phosphatase signaling pathway
Authors:
Open Access
- 28 May 2013
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 30 (2) , 757-762
Abstract
Insulin-like growth factor 1 (IGF-1) is a molecule with strong proliferative effects, and statins have been reported to exhibit antitumor effects based on clinical and experimental studies. However, their effects on cardiac myxoma (CM) cells and the underlying signaling mechanism(s) are largely unknown. Therefore, we investigated whether the protein/lipid phosphatases and tensin homolog deleted on chromosome ten (PTEN) and pleckstrin homology domain leucine-rich repeat phosphatase 1 and 2 (PHLPP1 and 2) are involved in the proliferative effect of IGF-1 on CM cells and the pharmacological impact of atorvastatin. The activity of PTEN and PHLPPs was determined using specific substrate diC16PIP3 and pNPP. We found that IGF-1 enhanced CM cell proliferation and inhibited both PTEN and PHLPP2 activity in a concentration- and time-dependent manner. Atorvastatin acted counter to IGF-1 and reversed the above effects mediated by IGF-1. Both IGF-1 and atorvastatin did not affect the activity of PHLPP1 and the protein expression of the three phosphatases. The results suggest that IGF-1 may exert its proliferative effects by negatively regulating the PTEN/PHLPP2 signaling pathway in CM cells, and atorvastatin may be a potential drug for the treatment of CM by enhancing the activity of PTEN and PHLPP2.Keywords
This publication has 36 references indexed in Scilit:
- Chemopreventive Efficacy of Atorvastatin against Nitrosamine-Induced Rat Bladder Cancer: Antioxidant, Anti-Proliferative and Anti-Inflammatory PropertiesInternational Journal of Molecular Sciences, 2012
- The differential effects of statins on the metastatic behaviour of prostate cancerBritish Journal of Cancer, 2012
- Atorvastatin correlates with decreased risk of esophageal cancer: a population-based case–control study from TaiwanLibyan Journal of Medicine, 2012
- Continuation With Statin Therapy and the Risk of Primary Cancer: A Population-Based StudyPreventing Chronic Disease, 2012
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer GrowthCancer Cell, 2011
- Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxelBritish Journal of Cancer, 2011
- Insulin-Like Growth Factor I Suppresses Bone Morphogenetic Protein Signaling in Prostate Cancer Cells by Activating mTOR SignalingCancer Research, 2010
- Purinergic Receptor-mediated Rapid Depletion of Nuclear Phosphorylated Akt Depends on Pleckstrin Homology Domain Leucine-rich Repeat Phosphatase, Calcineurin, Protein Phosphatase 2A, and PTEN PhosphatasesJournal of Biological Chemistry, 2010
- PHLPP-1 Negatively Regulates Akt Activity and Survival in the HeartCirculation Research, 2010
- Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignanciesMolecular Cancer Therapeutics, 2008